- Research Article
- 10.1016/j.diabres.2025.112641
Comparative study of medtronic 780G vs DIY closed loop systems in diabetes management
- Dec 01, 2025
- Diabetes Research and Clinical Practice
- V Chavda + 7 more +7
Publications from 2021 to 2026
Showing 10 of 64 papers
Comparative study of medtronic 780G vs DIY closed loop systems in diabetes management
Unveiling the Therapeutic Promise of Indole and Thiazole Derivatives in Treating Lung Diseases
Heterocyclic scaffolds, particularly indole and thiazole compounds, are revolutionizing the treatment of lung diseases due to their structural diversity and broad therapeutic potential. Their ability to target multiple biological pathways positions them as powerful tools for developing innovative treatments for lung disorders, particularly lung cancer. This review systematically explores recent advances in the synthesis and biological evaluation of indole and thiazole derivatives, emphasizing detailed synthetic strategies and the identification of the most potent molecules reported in the studies referenced within this manuscript for their relevance to lung diseases, particularly lung cancer. The SAR studies elucidate the role of molecular features and key functional groups in enhancing the potency, selectivity, and therapeutic efficacy of synthetic indole and thiazole derivatives. Given that lung cancer remains the leading cause of cancer-related deaths worldwide, the findings highlight the urgent need for developing innovative and effective anti-lung cancer agents, with indole and thiazole scaffolds serving as promising therapeutic frameworks.
Read moreEnhancing Surface Integrity of Al–Cu–Ni Composites with FeNb Reinforcement Through Laser Surface Melting
Ground Water Recharge- A Case Study of Raghunathpurwadi Village, Maharashtra
Challenges and Solutions in Rural Agriculture: A Holistic Perspective
Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1.
Sotagliflozin is the first dual SGLT1/2 inhibitor antidiabetic drug approved by the US Food and Drug Administration for the management of heart failure. SGLT1/2 inhibition is observed to potentiate the secretion of the incretin hormone, glucagon-like peptide-1 (GLP-1). The current preclinical research sought to investigate the effect of sotagliflozin on the secretion of fat-regulating peptides such as GLP-1, glucagon and fibroblast growth factor 21 (FGF21) and their prospective association with sotagliflozin's potential beneficial effects on dyslipidaemia. During an oral fat tolerance test in mice, sotagliflozin substantially increased GLP-1 and insulin concentrations. Although sotagliflozin alone did not ameliorate postprandial lipemia, its combination with linagliptin (DPP-IV inhibitor) significantly improved lipid tolerance comparable to orlistat (lipase inhibitor). In a triton-induced hypertriglyceridemia model, sotagliflozin, along with other medications (fenofibrate, exenatide and linagliptin) reduced fat excursion; however, co-administration with linagliptin provided no extra advantage. Furthermore, sotagliflozin stimulated glucagon secretion in the alpha TC1.6 cells and healthy mice, which resulted in an increased circulating FGF21 and β-hydroxybutyrate concentration. Finally, chronic treatment of sotagliflozin in high-fat diet (HFD)-fed obese mice resulted in reduced body weight gain, liver triglyceride, cholesterol, interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) levels compared with the placebo group. However, the addition of linagliptin did not provide any additional benefit. In conclusion, sotagliflozin was found to have an effect on GLP-1 and also stimulate the release of glucagon and FGF21, which are important for regulating fat metabolism. Therefore, sotagliflozin might represent a potential therapeutic approach for the treatment of diabetic dyslipidemia and steatohepatitis.
Read moreAssessment and cost analysis of mycoremediated textile effluent for irrigation
Abstract In the current study, mycoremediated textile effluents were used for irrigation in a cultivation system to promote resource recycling and cost‐effective spinach production. The raw textile effluents from two different textile mills were decolorized by 93.2 and 94.5%, respectively, as well as mineralized by the immobilized novel fungus Geotrichum candidum. Subsequently, both the treated effluents, treated textile effluent 1 (TTE1) and treated textile effluent 2 (TTE2), were used to cultivate spinach. The results indicated that irrigation with TTE1 and TTE2 resulted in ~9% higher spinach yields compared with the control. Moreover, the water use efficiency with the TTE1 and TTE2 treatments was ~1.2 times better than that with the control. The need for fertilizers in the case of spinach cultivation with treated effluents was compensated by the textile effluents as a result of the breakdown and mineralization of the effluent by immobilized G. candidum. Notably, the energy content, dietary fiber and protein content of spinach irrigated with mycoremediated textile effluent were substantially elevated, with values of 34 kcal/100 g−1, 3.4 g 100 g−1 and 6.92 g 100 g−1, respectively. The preliminary cost analysis indicated that the costs of the whole process (from treatment to irrigation) were approximately US$0.35‐0.38 m−3 (INR 28.22–30.45 m−3) of textile effluent. The study concluded that the mycoremediated textile effluent could be efficiently applied for agronomic usages.
Read moreDesign and development of efficient synthetic strategies for novel β-lactam enhancer WCK 5153 effective against gram-negative pathogens
Thermal Performance of Novel Liquid Cooled Disc Brake
Extremophiles and Their Genetic Aspects of Potential Bioactive/Metabolites Beneficial for Promoting Plant Health and Soil Fertility